355 related articles for article (PubMed ID: 35049227)
1. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
Huang QR; Li JW; Pan XB
Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
[TBL] [Abstract][Full Text] [Related]
2. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
Sun R; Pan Y; Mu L; Ma Y; Shen H; Long Y
Front Genet; 2021; 12():768930. PubMed ID: 34733320
[No Abstract] [Full Text] [Related]
3. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
Chen F; Wang Q; Zhou Y
BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
[TBL] [Abstract][Full Text] [Related]
4. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
Bi Y; Wu ZH; Cao F
BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
[TBL] [Abstract][Full Text] [Related]
6. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
7. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
8. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
9. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
[TBL] [Abstract][Full Text] [Related]
10. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
Wang D; Jiang Y; Wang T; Wang Z; Zou F
BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
[TBL] [Abstract][Full Text] [Related]
12. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
13. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
Front Oncol; 2022; 12():938679. PubMed ID: 35982954
[TBL] [Abstract][Full Text] [Related]
14. RNA Binding Protein-Based Model for Prognostic Prediction of Colorectal Cancer.
Li T; Hui W; Halike H; Gao F
Technol Cancer Res Treat; 2021; 20():15330338211019504. PubMed ID: 34080453
[TBL] [Abstract][Full Text] [Related]
15. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H
Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma.
Wang W; Xu SW; Zhu XY; Guo QY; Zhu M; Mao XL; Chen YH; Li SW; Luo WD
Front Genet; 2021; 12():665173. PubMed ID: 33981333
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
Chen Z; Wu T; Yan Z; Zhang M
Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer.
Du H; Li Y; Pang S; Enofe I; Pallante P; Zhu L; Hang J; Chen L
J Thorac Dis; 2023 Nov; 15(11):6178-6191. PubMed ID: 38090289
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
Zhao L; Zhang J; Xuan S; Liu Z; Wang Y; Zhao P
Front Cell Dev Biol; 2021; 9():600506. PubMed ID: 33614641
[No Abstract] [Full Text] [Related]
20. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
